1444380 - Nevro Corp - SEC Form 4 Insider Trading Screener

Manufactured Goods - Specialty Instruments - Surgical & Medical Instruments & Apparatus - NVRO (1444380)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
93 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
S14-1-4-2-12

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2018-09-17
NVROElghandour RamiPres, CEOM - OptEx$3.60+18,400129,653+17%+$66,240
2018-08-02
NVROChristoforou ChristoferVP, Research, DevelopmentF - Tax$59.55-86416,963-5%-$51,451
D
2018-08-01
NVROAlleavitch DougVP, QualityM - OptEx$53.70+1,00020,101+5%+$53,700
D
2018-07-25
NVROAlleavitch DougVP, QualityM - OptEx$53.70+1,50019,101+9%+$80,550
D
2018-07-18
NVROGalligan Andrew HCFOM - OptEx$1.44+7,40035,592+26%+$10,656
2018-06-01
NVROElghandour RamiPres, CEOF - Tax$77.44-7,894111,253-7%-$611,311
2018-05-21
NVROBehbahani AliDirA - Grant$0.00+3,7855,390+236%+$0
2018-05-21
NVROVale BradDirA - Grant$0.00+3,7857,303+108%+$0
2018-05-21
NVROMcCormick ShawnDirA - Grant$0.00+3,7855,303+249%+$0
2018-05-21
NVROJaeger Wilfred EDirA - Grant$0.00+3,785516,454+1%+$0
2018-05-21
NVROFischer Frank MDirA - Grant$0.00+3,78534,453+12%+$0
2018-05-21
NVROEarnhardt Lisa DDirA - Grant$0.00+3,7855,303+249%+$0
2018-05-21
NVRODemane Michael FDirA - Grant$0.00+3,785568,855+1%+$0
D
2018-05-14
NVROGalligan Andrew HCFOM - OptEx$18.00+7,00028,192+33%+$126,000
D
2018-05-14
NVROGalligan Andrew HCFOS - Sale+OE$76.14-7,00028,192-20%-$532,959
D
2018-05-11
NVRODemane Michael FDirM - OptEx$18.00+3,631565,070+1%+$65,358
2018-04-05
NVROSchmitz PatrickVP, OperationsF - Tax$88.69-38913,208-3%-$34,500
M
2018-03-05
NVROJaeger Wilfred EDirS - Sale$80.77-160,54212,560-93%-$12,966,669
D
2018-03-01
NVROGalligan Andrew HCFOM - OptEx$18.00+7,00028,192+33%+$126,000
D
2018-03-01
NVROGalligan Andrew HCFOS - Sale+OE$80.10-7,00028,192-20%-$560,711
M
2018-02-27
NVROJaeger Wilfred EDirS - Sale$82.19-39,45816,029-71%-$3,243,208
2018-01-03
NVROElghandour RamiPres, CEOF - Tax$71.17-3,019119,147-2%-$214,862
D
2017-12-21
NVRODemane Michael FDirM - OptEx$3.60+41,572561,439+8%+$149,659
D
2017-12-18
NVRORashid KashifGCA - Grant$0.00+10,00010,000New+$0
D
2017-12-12
NVROAlecxih JamesVP, SalesA - Grant$0.00+12,00012,000New+$0
D
2017-11-14
NVROSchmitz PatrickVP, OperationsA - Grant$0.00+6,50013,597+92%+$0
D
2017-11-14
NVROChristoforou ChristoferVP, Research, DevelopmentA - Grant$0.00+6,50017,827+57%+$0
D
2017-11-14
NVROAlleavitch DougVP, QualityA - Grant$0.00+6,50017,456+59%+$0
D
2017-11-14
NVROGalligan Andrew HCFOA - Grant$0.00+13,00028,192+86%+$0
D
2017-11-14
NVROGalligan Andrew HCFOM - OptEx$18.00+7,00028,192+33%+$126,000
D
2017-11-14
NVROGalligan Andrew HCFOS - Sale+OE$75.11-7,00028,192-20%-$525,740
D
2017-11-14
NVROElghandour RamiPres, CEOA - Grant$0.00+35,250122,166+41%+$0
D
2017-11-09
NVROGalligan Andrew HCFOM - OptEx$1.44+4,00015,192+36%+$5,760
2017-11-01
NVROSchmitz PatrickVP, OperationsF - Tax$88.99-3137,097-4%-$27,854
2017-11-01
NVROGalligan Andrew HCFOF - Tax$88.99-64111,192-5%-$57,043
2017-11-01
NVROChristoforou ChristoferVP, Research, DevelopmentF - Tax$88.99-23411,327-2%-$20,824
2017-11-01
NVROAlleavitch DougVP, QualityF - Tax$88.99-31310,956-3%-$27,854
2017-10-05
NVRODemane Michael FDirS - Sale$93.50-5,000519,867-1%-$467,500
2017-09-27
NVRODemane Michael FDirS - Sale$91.50-5,000524,867-1%-$457,500
2017-09-14
NVROJaeger Wilfred EDirS - Sale$90.19-16,46722,282-42%-$1,485,206
2017-09-13
NVRODemane Michael FDirS - Sale$89.50-5,000529,867-1%-$447,500
2017-09-11
NVRODemane Michael FDirS - Sale$87.73-25,000534,867-4%-$2,193,198
M
2017-08-22
NVROJaeger Wilfred EDirS - Sale$86.11-52,52022,638-70%-$4,522,376
M
2017-08-17
NVROJaeger Wilfred EDirS - Sale$84.28-40,34323,772-63%-$3,400,213
M
2017-08-14
NVROJaeger Wilfred EDirS - Sale$82.74-79,65724,643-76%-$6,590,574
D
2017-08-14
NVROGalligan Andrew HCFOM - OptEx$4.02+7,00011,833+145%+$28,138
D
2017-08-14
NVROGalligan Andrew HCFOS - Sale+OE$82.31-7,00011,833-37%-$576,192
2017-08-02
NVROChristoforou ChristoferVP, Research, DevelopmentF - Tax$82.00-93911,561-8%-$76,998
2017-06-01
NVROElghandour RamiPres, CEOF - Tax$69.74-8,30886,916-9%-$579,400
D
2017-05-25
NVRODemane Michael FDirA - Grant$0.00+1,518559,8670%+$0
D
2017-05-25
NVROVale BradDirA - Grant$0.00+1,5183,518+76%+$0
D
2017-05-25
NVROBehbahani AliDirA - Grant$0.00+1,5181,565>999%+$0
D
2017-05-25
NVROMcCormick ShawnDirA - Grant$0.00+1,5181,518New+$0
D
2017-05-25
NVROJaeger Wilfred EDirA - Grant$0.00+1,5181,151,6560%+$0
D
2017-05-25
NVROFischer Frank MDirA - Grant$0.00+1,51860,518+3%+$0
D
2017-05-25
NVROEarnhardt Lisa DDirA - Grant$0.00+1,5181,518New+$0
D
2017-05-15
NVROGalligan Andrew HCFOM - OptEx$3.60+7,50011,833+173%+$27,000
D
2017-05-15
NVROGalligan Andrew HCFOS - Sale+OE$75.30-7,50011,833-39%-$564,734
D
2017-05-09
NVROGalligan Andrew HCFOM - OptEx$1.44+5,00011,833+73%+$7,200-5
D
2017-05-01
NVROElghandour RamiPres, CEOM - OptEx$3.60+10,00095,224+12%+$36,000-4-22
D
2017-05-01
NVROElghandour RamiPres, CEOS - Sale+OE$95.03-10,00095,224-10%-$950,302-4-22
M
2017-05-01
NVRODemane Michael FDirS - Sale$96.07-29,800558,349-5%-$2,863,000-4-22
2017-04-05
NVROSchmitz PatrickVP, OperationsF - Tax$92.70-4237,410-5%-$39,2120-4-6
D
2017-04-04
NVROEnxing MichaelVP of SalesM - OptEx$3.60+1,50040,463+4%+$5,400-1-3-2
D
2017-04-04
NVROEnxing MichaelVP of SalesS - Sale+OE$93.53-1,50040,463-4%-$140,290-1-3-2
2017-04-04
NVRODemane Michael FDirS - Sale$93.39-22,200588,149-4%-$2,073,179-1-3-2
2017-04-03
NVROGalligan Andrew HCFOS - Sale$94.46-30,0006,833-81%-$2,833,829-1-3-2
D
2017-03-28
NVRODemane Michael FDirM - OptEx$4.33+13,620610,349+2%+$58,982-1-1+1
D
2017-03-06
NVROEnxing MichaelVP of SalesS - Sale+OE$91.01-38,50040,463-49%-$3,504,013-10+1
D
2017-03-06
NVROEnxing MichaelVP of SalesM - OptEx$3.60+1,50040,463+4%+$5,400-10+1
M
2017-03-01
NVROJaeger Wilfred EDirS - Sale$95.03-43,98024,847-64%-$4,179,531-4-3-1
D
2017-03-01
NVROGalligan Andrew HCFOM - OptEx$3.60+7,50036,833+26%+$27,000-4-3-1
D
2017-03-01
NVROGalligan Andrew HCFOS - Sale+OE$95.00-7,50036,833-17%-$712,531-4-3-1
2017-02-21
NVRODemane Michael FDirS - Sale$97.30-6,000596,729-1%-$583,800+5+1-3
D
2017-02-06
NVROEnxing MichaelVP of SalesM - OptEx$3.60+1,50077,463+2%+$5,400-1-1-2
D
2017-02-06
NVROEnxing MichaelVP of SalesS - Sale+OE$93.27-1,50077,463-2%-$139,908-1-1-2
D
2017-01-26
NVROEnxing MichaelVP of SalesM - OptEx$3.60+37,00077,463+91%+$133,200+2+11+15
D
2017-01-03
NVROElghandour RamiPres, CEOA - Grant$0.00+31,04495,224+48%+$0+1+8+21
D
2017-01-04
NVROEnxing MichaelVP of SalesM - OptEx$3.60+1,50040,463+4%+$5,400+1+8+21
D
2017-01-04
NVROEnxing MichaelVP of SalesS - Sale+OE$75.88-1,50040,463-4%-$113,824+1+8+21
D
2016-12-05
NVROEnxing MichaelVP of SalesM - OptEx$3.60+1,50040,463+4%+$5,400-1-3-1
D
2016-12-05
NVROEnxing MichaelVP of SalesS - Sale+OE$76.38-1,50040,463-4%-$114,573-1-3-1
D
2016-11-30
NVRODemane Michael FDirM - OptEx$3.60+10,000602,729+2%+$36,000+4+40
D
2016-11-16
NVROSchmitz PatrickVP, OperationsA - Grant$0.00+3,3337,833+74%+$0-3-4-18
D
2016-11-16
NVROEnxing MichaelVP of SalesA - Grant$0.00+2,50040,463+7%+$0-3-4-18
D
2016-11-16
NVROAlleavitch DougVP, QualityA - Grant$0.00+3,33310,984+44%+$0-3-4-18
D
2016-11-16
NVROChristoforou ChristoferVP, Research, DevelopmentA - Grant$0.00+2,50012,500+25%+$0-3-4-18
D
2016-11-16
NVROGalligan Andrew HCFOA - Grant$0.00+6,83336,833+23%+$0-3-4-18
D
2016-11-15
NVROGalligan Andrew HCFOM - OptEx$11.64+7,50030,000+33%+$87,264+1-1-15
D
2016-11-15
NVROGalligan Andrew HCFOS - Sale+OE$86.90-7,50030,000-20%-$651,754+1-1-15
D
2016-11-08
NVRODemane Michael FDirM - OptEx$3.60+30,000592,729+5%+$108,000+1+6-8-10
D
2016-11-04
NVROEnxing MichaelVP of SalesM - OptEx$3.60+1,50037,963+4%+$5,400-5-6-12-12
D
2016-11-04
NVROEnxing MichaelVP of SalesS - Sale+OE$86.24-1,50037,963-4%-$129,361-5-6-12-12
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top